TP53 and pancreatic neoplasm: A study reported for the first time that, when combined with cisplatin, MI-319 induced cell growth inhibition and apoptosis in pancreatic cancer cells regardless of the mutational status of their p53, as reduced tumor growth was observed in both wt-p53 and mut-p53 tumor xenograft models.